Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

On The Pen: The Weekly Dose 6.25.24

On The Pen: The Weekly Dose 6.25.24

FromOn The Pen: The Weekly Dose


On The Pen: The Weekly Dose 6.25.24

FromOn The Pen: The Weekly Dose

ratings:
Length:
19 minutes
Released:
Jun 25, 2024
Format:
Podcast episode

Description

Send us a Text Message.Novo Nordisk expansion in the US:https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=168528Generic liraglutidehttps://www.onthepen.com/post/teva-launches-first-ever-generic-glp-1-a-game-changer-for-diabetes-and-weight-managementNew Wegovy Coupon:https://www.wegovy.com/coverage-and-savings/save-on-wegovy.htmlNew Mounjaro Card (tiktok video)https://mounjaro.lilly.com/savings-resourcesTirzepatide (tiktok video):https://www.reuters.com/business/healthcare-pharmaceuticals/weight-loss-drug-zepbound-resolves-sleep-apnea-up-52-patients-lilly-says-2024-06-21/Petrelintidehttps://www.onthepen.com/post/introducing-petrelintide-discover-the-promise-of-amalyn-agonist-medications-for-weight-lossGut bacteria:Interesting research that shows that type-2 diabetics have more microbiome in their gut that suppresses incretin hormones like GLP-1. This is more evidence that #glp1 medications fix what is biologically brokenhttps://www.onthepen.com/post/glp-1-slow-responders-gut-bacteria-may-hold-the-keyDACRA:https://ir.vikingtherapeutics.com/2024-06-24-Viking-Therapeutics-Presents-Preclinical-Data-on-Novel-Dual-Amylin-and-Calcitonin-Receptor-Agonists-at-84th-Scientific-Sessions-of-the-American-Diabetes-AssociationSupport the Show.MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaro? Contact Me: MounjaroMan@gmail.com? PLAYLISTS:?️ ON THE PEN LIVES:https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM? WATCH MY MOUNJARO JOURNEY IN ORDER:https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO? NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW?? ALL THE LATEST MOUNJARO NEWS:https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yBThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.
Released:
Jun 25, 2024
Format:
Podcast episode

Titles in the series (36)

Get your weekly dose of everything in the news about incretin mimetic therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!